1475:TYO
BRJ iShares Core TOPIX ETF
ā§Ēā§¨ā§Ģ.ā§Ŧā§Ļ JPÂĨ
arrow_upward
+ā§Ļ.ā§Ēā§Ģ%(+ā§§.ā§¯ā§Ļ) ā§§ āĻĻāĻŋ
ā§¯ āĻ
āĻā§āĻā§, ā§Š:ā§Šā§Ļ:ā§Ļā§Ļ PM GMT +ā§¯ · JPY
search
āĻ¸āĻŦ āĻ¸āĻŋāĻŽā§āĻŦāĻ˛
| āĻ¸āĻŋāĻŽā§āĻŦāĻ˛ | āĻĻāĻžāĻŽ | āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ āĻāĻ°ā§āĻ¨ | % āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|
insights_auto1475-āĻāĻ° āĻāĻ¨ā§āĻ¯ āĻ¸ā§āĻ°āĻž āĻāĻ¨āĻ¸āĻžāĻāĻ āĻā§āĻ¨āĻžāĻ°ā§āĻ āĻāĻ°āĻž āĻšāĻā§āĻā§...
āĻā§āĻ˛ā§āĻ¨
ā§Ēā§¨ā§Ē JPÂĨ
āĻ¸āĻ°ā§āĻŦāĻžāĻ§āĻŋāĻ
ā§Ēā§¨ā§Ŧ JPÂĨ
āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨
ā§Ēā§¨ā§¨Â JPÂĨ
āĻ
ā§āĻ¯āĻžāĻāĻžāĻ°ā§āĻ āĻāĻ˛āĻŋāĻāĻŽ
ā§Šā§§.ā§Ēā§Ŧ āĻ˛āĻž
āĻāĻ˛āĻŋāĻāĻŽ
ā§¨ā§.ā§Žā§¯Â āĻ˛āĻž
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§Ēā§Šā§Ģ JPÂĨ
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨ āĻĻāĻžāĻŽ
ā§Šā§¨ā§¨Â JPÂĨ
āĻā§āĻ˛ā§āĻ¨
ā§Ēā§¨ā§Ē JPÂĨ
āĻ¸āĻ°ā§āĻŦāĻžāĻ§āĻŋāĻ
ā§Ēā§¨ā§Ŧ JPÂĨ
āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨
ā§Ēā§¨ā§¨Â JPÂĨ
āĻ
ā§āĻ¯āĻžāĻāĻžāĻ°ā§āĻ āĻāĻ˛āĻŋāĻāĻŽ
ā§Šā§§.ā§Ēā§Ŧ āĻ˛āĻž
āĻāĻ˛āĻŋāĻāĻŽ
ā§¨ā§.ā§Žā§¯Â āĻ˛āĻž
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§Ēā§Šā§Ģ JPÂĨ
ā§Ģā§¨ āĻ¸āĻĒā§āĻ¤āĻžāĻšā§āĻ° āĻ¸āĻ°ā§āĻŦāĻ¨āĻŋāĻŽā§āĻ¨ āĻĻāĻžāĻŽ
ā§Šā§¨ā§¨Â JPÂĨ
āĻāĻ āĻ§āĻ°āĻ¨ā§āĻ° āĻāĻ°āĻ āĻ
ā§āĻ¯āĻžāĻ¸ā§āĻ
āĻāĻŦāĻ°ā§āĻ° āĻ¸ā§āĻā§āĻ°āĻŋ
āĻā§ā§āĻŦ āĻ¸ā§āĻ°ā§āĻ¸ āĻ āĻāĻŦāĻ°ā§āĻ° āĻĒāĻžāĻ°ā§āĻāĻ¨āĻžāĻ°āĻĻā§āĻ° āĻĨā§āĻā§
Yahoo Finance
·
ā§§ āĻāĻŖā§āĻāĻž āĻāĻā§
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
pharmaphorum
·
ā§Ēā§Ž āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
Iambic prices its IPO, seeking to raise up to $160m
The Tech Buzz
·
ā§§ āĻāĻŖā§āĻāĻž āĻāĻā§
Nasdaq CEO: Tokenization Could Free Tens of Billions in Capital
Seeking Alpha
·
ā§Ēā§§ āĻŽāĻŋāĻ¨āĻŋāĻ āĻāĻā§
S&P 500 Sector Outlook: Favor XLC And XLK, Underweight XLP With Uneven Earnings Leadership